Effect of Boysenberry apple powder blend (BerriQi) on reducing symptom severity in children with Upper respiratory tract infection

The study evaluated the efficacy of a natural supplement BerriQi (a blend of boysenberries and apples) for treating upper respiratory tract infections in children. A double-blind, randomized, placebo-controlled trial included 84 children aged 5 to 13 years who received BerriQi or placebo for 14 days. Both groups showed progressive reduction in symptom severity during the study. The BerriQi group had significantly lower total symptom severity (P=0.04) and showed a trend toward improved functional scores (P=0.05). Children taking BerriQi missed school for an average of 8 days compared to 11 days in the placebo group. The results suggest that BerriQi may be a promising natural supplement for alleviating respiratory infection symptoms and supporting faster functional recovery in children.